Allworth Financial LP Vor Biopharma Inc. Transaction History
Allworth Financial LP
- $20.2 Billion
- Q2 2025
A detailed history of Allworth Financial LP transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Allworth Financial LP holds 60 shares of VOR stock, worth $1,211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60Holding current value
$1,211% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VOR
# of Institutions
41Shares Held
55.7MCall Options Held
4.15MPut Options Held
364K-
Ra Capital Management, L.P. Boston, MA39.6MShares$800 Million1.4% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$128 Million6.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$38.7 Million0.0% of portfolio
-
Ubs Group Ag1.53MShares$30.9 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$21.7 Million0.59% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $768M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...